784 filings
Page 9 of 40
8-K
CRVO
CervoMed Inc
28 Jun 22
Diffusion Pharmaceuticals Announces Positive Effects in Altitude Trial
4:13pm
4
CRVO
CervoMed Inc
2 Jun 22
Diffusion Pharmaceuticals / Jane H Hollingsworth ownership change
8:37pm
8-K
CRVO
CervoMed Inc
23 May 22
Diffusion Pharmaceuticals Announces Appointment of Raven Jaeger, M.S., as Chief Regulatory Officer
5:42pm
8-K
CRVO
CervoMed Inc
16 May 22
Diffusion Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update
12:00am
10-Q
2022 Q1
CRVO
CervoMed Inc
Quarterly report
12 May 22
4:23pm
8-K
CRVO
CervoMed Inc
4 May 22
Other Events
4:33pm
4
CRVO
CervoMed Inc
3 May 22
Diffusion Pharmaceuticals / Robert Joseph Jr. Cobuzzi ownership change
6:24pm
4
CRVO
CervoMed Inc
19 Apr 22
Diffusion Pharmaceuticals / Robert Joseph Jr. Cobuzzi ownership change
5:18pm
4
CRVO
CervoMed Inc
19 Apr 22
Diffusion Pharmaceuticals / WILLIAM ROBERT ELDER ownership change
5:17pm
8-K
CRVO
CervoMed Inc
18 Apr 22
Diffusion Pharmaceuticals Announces 1-for-50 Reverse Stock Split as Part of Nasdaq Compliance Plan
4:25pm
8-K
CRVO
CervoMed Inc
12 Apr 22
Diffusion Pharmaceuticals Completes Dosing in Altitude Trial
9:08am
DEFA14A
CRVO
CervoMed Inc
8 Apr 22
Additional proxy soliciting materials
5:05pm
8-K
CRVO
CervoMed Inc
8 Apr 22
Diffusion Pharmaceuticals Announces New Date for Previously Announced Special Meeting of Stockholders
5:04pm
DEFA14A
CRVO
CervoMed Inc
30 Mar 22
Additional proxy soliciting materials
4:33pm
DEF 14A
CRVO
CervoMed Inc
Definitive proxy
28 Mar 22
5:24pm
4
William Robert Elder
22 Mar 22
Diffusion Pharmaceuticals / WILLIAM ROBERT ELDER ownership change
7:30am
4
CRVO
CervoMed Inc
22 Mar 22
Diffusion Pharmaceuticals / Robert Joseph Jr. Cobuzzi ownership change
7:30am
8-K
CRVO
CervoMed Inc
21 Mar 22
Diffusion Pharmaceuticals Reports 2021 Financial Results and Provides Business Update
4:26pm
PRE 14A
CRVO
CervoMed Inc
Preliminary proxy
18 Mar 22
5:41pm
8-K
CRVO
CervoMed Inc
18 Mar 22
Entry into a Material Definitive Agreement
5:14pm